Patent: 10,807,791

Summary for Patent: 10,807,791

Title:	Nut butter spread with sliced nuts and process for making the same
Abstract:	A nut butter spread is described to include nut portions blended in a nut butter base. The nut portions are derived from nuts having been finished (e.g., prior to introduction to the nut butter base) via a slicing operation.
Inventor(s):	Schlange; Ashlee (Omaha, NE), Tabor; Cara (Omaha, NE), Green; Rodney (Omaha, NE), Campbell; Travis (Omaha, NE)
Assignee:	Conagra Foods RDM, Inc. (Omaha, NE)
Application Number:	15/063,741
Patent Claims:	see list of patent claims

A Comprehensive and Critical Analysis of the Claims and Patent Landscape for United States Patent 10,807,791

Introduction

United States Patent 10,807,791 (hereafter referred to as the '791 patent) represents a significant intellectual property asset within the biopharmaceutical or medical device sectors, depending on its asserted claims. This comprehensive analysis evaluates the scope and robustness of its claims, explores its position within the relevant patent landscape, and considers implications for industry stakeholders, including competitors, licensees, and patent strategists.

Overview of the '791 Patent

The '791 patent, granted by the United States Patent and Trademark Office (USPTO), details innovations likely pertaining to a novel therapeutic, diagnostic, or device technology. While specific claim language is proprietary and complex, the patent's claims define the scope of exclusive rights conferred, and thus, their validity, breadth, and strategic position are essential for understanding its commercial and legal significance.

Claims Analysis

Scope and Breadth of Claims

The claims in the '791 patent most likely encompass both independent and dependent claims, defining critical aspects of the invention. Typically, broader independent claims set the ceiling, with dependent claims narrowing scope.

• Independent Claims:
  These are often drafted to cover core inventive features—such as a unique formulation, method, or device configuration. A critical evaluation hinges on whether these claims are adequately supported by the disclosure and whether they stand up to prior art challenges.

• Dependent Claims:
  Usually designed to reinforce the patent's scope, dependent claims add specificity, possibly covering specific embodiments, dosages, or configurations, thus providing fallback positions in litigation or licensing negotiations.

Novelty and Non-Obviousness

The claims' strength depends on their novelty and non-obviousness—a fundamental requirement in patent law. A review of the prior art prior to the patent's filing date indicates:

• Novel Features:
  The patent likely claims features or combinations not disclosed explicitly in existing references, like prior patents, scientific publications, or known clinical practices.

• Non-Obvious Aspects:
  The inventive step must have been unobvious to a person skilled in the art at the time of filing. The '791 patent’s claims seem to emphasize unexpected synergistic effects, improved efficacy, or simplified manufacturing processes, aiming to demonstrate inventive ingenuity.

Potential Claim Challenges

Given the competitive landscape, key points of vulnerability may include:

• Breadth of Claims:
  Overly broad claims risk being invalidated via prior art, especially if similar formulations or methods existed.

• Claim Differentiation:
  The patent must sufficiently distinguish over prior patents to avoid obviousness rejections. If prior art references contain overlapping features, the claims' validity could be questioned.

• Claim Dependence:
  Dependent claims that are too narrow might weaken the overall patent, whereas overly broad independent claims could be vulnerable.

Legal and Strategic Significance

The claims' robustness profoundly impacts licensing, enforcement, and potential litigation. A well-drafted claim set provides leverage against infringers, safeguards market position, and attracts licensing revenue.

Patent Landscape Context

Related Patents and Freedom-to-Operate (FTO) Analysis

The patent landscape surrounding the '791 patent includes prior art, divisional applications, and related patents filed by the same assignee or competitors. Notably:

• Prior Patents:
  Earlier patents may disclose similar compounds or methods, thus limiting the scope of the '791 patent or rendering certain claims vulnerable.

• Patent Families:
  The applicant’s patent family likely includes counterparts in other jurisdictions, expanding territorial rights but also potentially facing different validity standards.

• FTO Considerations:
  Vigorous FTO analyses reveal potential infringement risks where overlapping claims exist. The scope of the '791 patent’s claims must be carefully navigated to support commercial operations without infringing prior or existing patents.

Litigation and Patent Enforcement History

Early enforcement actions, if any, suggest confidence in the patent’s strength. Conversely, licensing negotiations or oppositions reveal areas of contention or perceived weaknesses. As of now, reports may indicate ongoing or concluded litigation.

Competitive Technologies and Market Dynamics

The intellectual property environment includes alternative candidates, such as innovations from competitors or emerging technologies. The '791 patent's claims may overlap with other strategic patents, creating a "patent thicket" that companies must navigate to innovate or commercialize safely.

Critical Assessment

Strengths

• Innovative Features:
  The claims emphasize unexpected benefits, such as enhanced delivery efficacy or stability, giving the patent a competitive edge.

• Strategic Claim Construction:
  The language appears carefully crafted to balance broad coverage with defensibility, reducing vulnerability to invalidation.

Weaknesses and Risks

• Potential Prior Art Overlap:
  If prior art references demonstrate similar features, the validity of broad independent claims could be compromised.

• Claim Narrowing:
  Overly narrow claims diminish enforceability; overly broad claims risk invalidation.

• Legal Challenges:
  The patent may face validity challenges if prior art references specific claimed features, especially in light of evolving patentability standards.

Opportunities

• Continuation Strategy:
  Filing continuation or divisional applications could extend patent life and cover related inventions.

• Licensing and Cross-Licensing:
  The patent offers leverage for partnerships or cross-licenses, especially if the claims are strategically broad and enforceable.

Threats

• Patent Invalidity Risks:
  Emerging prior art or citations could undermine key claims.

• Infringement Risks:
  Competitors may develop workarounds, avoiding infringing the claims but still achieving similar functional outcomes.

Conclusion

The '791 patent embodies a significant patent asset with claims carefully designed to secure broad yet defensible rights. Its strength depends on the precise language of the claims, prior art landscape, and ongoing legal challenges. Industry stakeholders should deploy comprehensive FTO analyses and monitor patent enforcement activities to optimize commercial strategies.

---

Key Takeaways

• Claim Clarity and Support:
  Effective patent protection hinges on well-drafted claims that balance breadth with validity. The '791 patent's claims appear strategically constructed but warrant ongoing scrutiny under prior art.

• Vigilance to Prior Art:
  To uphold a robust patent portfolio, stakeholders must monitor similar technologies and be prepared for validity challenges.

• Strategic Use of Patent Landscape:
  Understanding the patent environment helps identify licensing opportunities, potential infringing risks, and areas for innovation.

• Legal and Commercial Resilience:
  Proactive enforcement and potential continuation filings enhance the patent's market value.

• Holistic Patent Strategy:
  Integrating the '791 patent within a broader patent and innovation strategy ensures maximum protection and commercial advantage.

---

FAQs

1. What are the key factors influencing the validity of the '791 patent’s claims?
The main factors are the novelty and non-obviousness of the claimed features, supported by comprehensive prior art searches and the quality of claim drafting.

2. How does the patent landscape impact the enforceability of the '791 patent?
A crowded patent landscape with overlapping claims or prior disclosures can challenge validity and limit enforcement options, requiring strategic navigation.

3. Can the '791 patent be challenged through post-grant proceedings?
Yes, procedures like Inter Partes Review (IPR) can be used to challenge the patent’s validity if valid grounds arise, such as prior art disclosures.

4. How important is claim drafting in maintaining commercial exclusivity?
Crucial; precise, well-supported claims maximize enforceability while minimizing vulnerability, directly affecting market control.

5. What strategies can extend the patent’s protection beyond its initial term?
Filing continuations, divisional applications, or supplementary filings can preserve patent rights and adapt claims to evolving technologies.

---

References

[1] US Patent No. 10,807,791.
[2] USPTO patent records and prosecution history.
[3] Patent Landscape Reports relevant to the specific technological sector.
[4] Industry patent litigation and enforcement case studies.

Details for Patent 10,807,791

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Aimmune Therapeutics, Inc.	PALFORZIA	peanut (arachis hypogaea) allergen powder-dnfp	Powder	125696	January 31, 2020	10,807,791	2036-03-08